We provide tailored solutions to pharmaceutical and medtech companies in need of (companion) diagnostic solutions. Using our microRNA platform we support activities for biomarker discovery, validation and industrialization.
Biomarker development at TAmiRNA relies on the same qPCR platform throughout the entire development life-cycle. There is no need to perform technology bridging studies after discovery or validation in order to achieve industrialization.
We collaborate with the best companies to develop diagnostic, prognostic or predictive algorithms for our biomarker panels.
We have developed a software solution that integrates the diagnostic algorithms seamless with the analytical workflow. It has been developed to provide a customized data output in a highly standardized manner.
We have implemented a quality management system according to ISO standards, which ensures the highest quality standard for our activities.